Clinical trials
Enrolling by invitation Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| A2 Biotherapeutics Inc. | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Georgetown University | 1 |
| HealthPartners Institute | 1 |
| Medical University of Silesia | 1 |
| National Cancer Institute (NCI) | 1 |
| Shenzhen Geno-Immune Medical Institute | 1 |
| Tobias Moeller-Bertram | 1 |
| Yonsei University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 9 |
| Breast Neoplasms | 3 |
| Prostatic Neoplasms | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Angina, Stable | 1 |
| Anxiety Disorders | 1 |
| Arthritis, Rheumatoid | 1 |
| Asthma | 1 |
| Atrial Fibrillation | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.